Matthew D Linnik Selected Research

SRI-5 (SRI 5)

1/2018

Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew D Linnik Research Topics

Disease

6	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2006 - 12/2002
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 02/2003
3	Autoimmune Diseases (Autoimmune Disease) 10/2023 - 11/2003
3	Lupus Nephritis 08/2008 - 04/2005
2	Rheumatoid Arthritis 03/2024 - 03/2011
2	Arthritis (Polyarthritis) 01/2021 - 01/2018
2	Infections 01/2018 - 03/2011
2	Pneumonia (Pneumonitis) 03/2011 - 02/2008
2	Inflammation (Inflammations) 04/2006 - 11/2005
2	Thrombosis (Thrombus) 05/2004 - 06/2002
1	Experimental Arthritis 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Exanthema (Rash) 01/2018
1	Proteinuria 08/2008
1	Ischemia 04/2006
1	Ulcerative Colitis 11/2005
1	Endotoxemia 11/2005
1	Body Weight (Weight, Body) 11/2005
1	Colitis 11/2005
1	Stroke (Strokes) 05/2004

Drug/Important Bio-Agent (IBA)

5	AntibodiesIBA 08/2006 - 06/2002
4	AutoantibodiesIBA 08/2004 - 12/2002
3	abetimusIBA 08/2008 - 02/2003
3	anti-dsDNA autoantibodyIBA 08/2008 - 04/2005
3	beta 2-Glycoprotein I (Apolipoprotein H)IBA 08/2004 - 12/2002
2	CytokinesIBA 01/2021 - 11/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011 - 11/2005
2	DNA (Deoxyribonucleic Acid)IBA 08/2008 - 04/2005
2	hydrazine (hydrazine dihydrochloride)IBA 04/2006 - 11/2005
2	human AOC3 proteinIBA 04/2006 - 11/2005
2	N'-(2-phenylallyl)hydrazineIBA 04/2006 - 11/2005
1	poseltinibIBA 01/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	baricitinibIBA 01/2018
1	SRI-5 (SRI 5)IBA 01/2018
1	Janus KinasesIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	tabalumabIBA 01/2017
1	Adalimumab (Humira)FDA Link 03/2011
1	Tumor Necrosis Factor InhibitorsIBA 03/2011
1	Rituximab (Mabthera)FDA Link 03/2011
1	Methotrexate (Mexate)FDA LinkGeneric 03/2011
1	Etanercept (Enbrel)FDA Link 03/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2008
1	Investigational DrugsIBA 08/2008
1	OligonucleotidesIBA 08/2008
1	3-fluoro-2-(4-methoxybenzyl)allylamineIBA 02/2008
1	Estrogens (Estrogen)FDA Link 04/2006
1	CarrageenanIBA 11/2005
1	Interleukin-6 (Interleukin 6)IBA 11/2005
1	LipopolysaccharidesIBA 11/2005
1	Blood Proteins (Serum Proteins)IBA 08/2004
1	Anticardiolipin AntibodiesIBA 05/2004

Therapy/Procedure

2	Therapeutics 10/2023 - 01/2018
1	Lasers (Laser) 03/2024
1	Estrogen Replacement Therapy 04/2006